Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3213688 | 1.00 | CES2 (0.48) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL5279943 | 1.00 | CES2 (0.48) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL5860239 | 1.00 | CES2 (0.48) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL11071652 | 1.00 | CES2 (0.48) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL2231045 | 1.00 | CES2 (0.48) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL5859421 | 1.00 | CES2 (0.48) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL344074 | 1.00 | CES2 (0.48) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL9953987 | 1.00 | CES2 (0.48) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL21269866 | 1.00 | CES2 (0.48) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL337636 | 1.00 | CES2 (0.48) | CES2GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220265857-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | MODERNATX, INC. (US) | 2022-08-25 | — | — | US | disclosed |
| EP-3386484-B1 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS | MODERNATX INC (US) | 2022-03-30 | — | — | EP | disclosed |
| US-11285222-B2 | Compositions and methods for delivery of agents | MODERNATX, INC. (US) | 2022-03-29 | — | — | US | disclosed |
| US-20200206362-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | Moderna TX, Inc. (US) | 2020-07-02 | — | — | US | disclosed |
| US-20200206362-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | Moderna TX, Inc. (US) | 2020-07-02 | — | — | US | disclosed |
| US-10556018-B2 | Compositions and methods for delivery of agents | ARES CAPITAL CORPORATION, AS AGENT | 2020-02-11 | — | — | US | disclosed |
| US-10556018-B2 | Compositions and methods for delivery of agents | ARES CAPITAL CORPORATION, AS AGENT | 2020-02-11 | — | — | US | disclosed |
| US-20190117798-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | MODERNATX, INC. (US) | 2019-04-25 | — | — | US | disclosed |
| US-20190117798-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | MODERNATX, INC. (US) | 2019-04-25 | — | — | US | disclosed |
| US-10207010-B2 | Compositions and methods for delivery of agents | MODERNATX, INC. (US) | 2019-02-19 | — | — | US | disclosed |
| US-5521138-A | COLOR DEVELOPMENT AND CRYSTALLIZATION | RICOH COMPANY, LTD. (JP) | 1996-05-28 | — | — | US | disclosed |
| US-5517228-A | Apparatus for displaying a recording medium sheet and printing an image thereon | RICOH CO., LTD. (JP) | 1996-05-14 | — | — | US | disclosed |
| US-5432534-A | Reversible thermosensitive coloring composition, recording medium, recording method, and image display apparatus using the recording medium | RICOH COMPANY, LTD. (JP) | 1995-07-11 | — | — | US | disclosed |
| US-5395433-A | Containing electron donor coloring and electron acceptor compounds which react to induce color formation; printers for computers, facsimile apparatus | RICOH COMPANY, LTD. (JP) | 1995-03-07 | — | — | US | disclosed |
| US-5379058-A | Recording apparatus using a thermosensitive recording medium | RICOH COMPANY, LTD. (JP) | 1995-01-03 | — | — | US | disclosed |
| US-5296439-A | Support with reversible thermosensitive coloring recording layer containing electron donor coloring compound, electron acceptor which reacts to induce color formation | RICOH COMPANY, LTD. (JP) | 1994-03-22 | — | — | US | disclosed |
| EP-0576015-A1 | Method of reversible recording | Ricoh Company, Ltd (JP) | 1993-12-29 | — | — | EP | disclosed |
| EP-0492628-A1 | Reversible thermosensitive coloring composition, recording medium, recording method and image display apparatus using the recording medium | Ricoh Company, Ltd (JP) | 1992-07-01 | — | — | EP | disclosed |
| US-4157916-A | Silver halide photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1979-06-12 | — | — | US | disclosed |
| US-3950382-A | STABILIZERS FOR POLYOLEFINS | CIBA-GEIGY CORPORATION (US) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190117798-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | HDLBP, APOB, TSG101 | CES2 1430/4885GPR84 3726/4885PPARG 3597/4885 |
| US-10556018-B2 | Compositions and methods for delivery of agents | HDLBP, APOB, TSG101 | CES2 1430/4885GPR84 3726/4885PPARG 3597/4885 |
| US-20200206362-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | HDLBP, APOB, TSG101 | CES2 1430/4885GPR84 3726/4885PPARG 3597/4885 |
| US-10207010-B2 | Compositions and methods for delivery of agents | HDLBP, APOB, TSG101 | CES2 1430/4885GPR84 3726/4885PPARG 3597/4885 |
| US-11285222-B2 | Compositions and methods for delivery of agents | HDLBP, APOB, TSG101 | CES2 1430/4885GPR84 3726/4885PPARG 3597/4885 |
| US-20220265857-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | HDLBP, APOB, TSG101 | CES2 1430/4885GPR84 3726/4885PPARG 3597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.